No black box warning on record for Vectibix

As of the latest FDA labeling reviewed, Vectibix (PANITUMUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Vectibix medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Dermatologic and Soft Tissue Toxicity: Monitor for dermatologic and soft tissue toxicities. Reduce dose for recurrent Grade 3 toxicity and withhold or discontinue Vectibix for severe or life-threatening complications. Limit sun exposure. ( 2.3 , 5.1 , 5.7 ) Increased tumor progression, increased mortality, or lack of benefit in patients with RAS -mutant mCRC, receiving V

No black box warning on record for Vectibix

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Dermatologic and Soft Tissue Toxicity: Monitor for dermatologic and soft tissue toxicities. Reduce dose for recurrent Grade 3 toxicity and withhold or discontinue Vectibix for severe or life-threatening complications. Limit sun exposure. ( 2.3 , 5.1 , 5.7 ) Increased tumor progression, increased mortality, or lack of benefit in patients with RAS -mutant mCRC, receiving V

Vectibix Black Box Warning

No black box warning on record for Vectibix

Other warnings & precautions

Vectibix Black Box Warning

No black box warning on record for Vectibix

Other warnings & precautions